References
- Bibby M.C., Double J.A., Phillips R.M., Loadman P.M. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). British Journal of Cancer 1987; 55: 159–163
- Ching L.-M., Baguley B.C. Induction of natural killer cell activity by the antitumor compound flavone acetic acid (NSC347512). European Journal of Cancer and Clinical Oncology 1987; 23: 1047–1050
- Ching L.-M., Baguley B.C. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC347512). European Journal of Cancer and Clinical Oncology 1988; 24: 1521–1525
- Corbett T.H., Bissery M.-C., Wozniak A., Plowman P., Polin L., Tapazoglou E., Dieckman J., Valeriote F. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice. Investigational New Drugs 1986; 4: 207–220
- Evelhoch J.L., Bissery M.-C., Chabot G.G., Simpson N.E., McCoy C.L., Heilbrun L.K., Corbett T.H. Flavone acetic acid (NSC347512)-induced modulation of murine tumor physiology monitored by in vivo magnetic resonance spectroscopy. Cancer Research 1988; 48: 4749–4755
- Finlay G.J., Smith G.P., Fray L.M., Baguley B.C. Effect of flavone acetic acid on Lewis Lung carcinoma: evidence for an indirect effect. Journal of the National Cancer Institute 1988; 80: 241–245
- Hill S.A., Williams K.B., Denekamp J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. European Journal of Cancer and Clinical Oncology 1989; 25: 1419–1424
- Hornung R.L., Young H.A., Urba W.J., Wiltrout R.H. Immunomodulation of natural killer activity by flavone acetic acid: occurrence via induction of interferon alpha/beta. Journal of the National Cancer Institute 1988; 80: 1226–1231
- Kerr D.J., Maughan T., Newlands E., Rustin G., Bleehen N.M., Lewis C., Kaye S.B. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal cancer. British Journal of Cancer 1989; 60: 104–106
- Mace K.F., Hornung R.L., Wiltrout R.H., Young H.A. Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer. Cancer Research 1990; 50: 1742–1747
- Murray J.C., Smith K.A., Thurston G. Flavone acetic acid induces a coagulopathy in mice. British Journal of Cancer 1989; 60: 729–733
- Sapirstein L.A. Regional blood flow by fractional distribution of indicators. American Journal of Physiology 1958; 193: 161–168
- Smith K.A., Thurston G., Murray J.C. Systemic effects of FAA are enhanced by implanted tumours. International Journal of Radiation Biology 1991; 60: 387–391
- Zwi L.J., Baguley B.C., Gavin J.B., Wilson W.R. Blood flow failure as a major determinant in the antitumour action of flavone acetic acid. Journal of the National Cancer Institute 1989; 81: 1005–1013